A potent group of antipsychotic drugs used to treat delirium and dementia are not effective, according to a study published in the New England…
A report by the AARP has found that most dementia patients—around 70 percent—are kept on prescription drugs much longer than they’ve been found to be…
A drug group known as benzodiazepines—commonly referred to as ‘benzos’—has been linked to an increased risk of Alzheimer’s disease, according to a new study….
The long search for a drug to slow the decline of Alzheimer’s may have reached a turning point. Pharmaceutical companies Biogen and Eisai have…
We know that as much as 50 percent of dementia patients experience regular pain. But does providing a common painkiller help or hurt patients?…
After years of failure, including some pharmaceutical companies calling off Alzheimer’s research altogether, Biogen offers a glimmer of hope: New data from a Phase…
Could an aspirin a day keep dementia away? A new study has added to the list of evidence that anti-inflammatories like aspirin might be…
Sign up for a weekly digest of the latest research on Alzheimer’s and brain health.
Follow us